New diabetes clinical trial: Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease

Published on: August 15, 2019 at 09:30PM
Conditions:   Type 2 Diabetes;   Cardiovascular Diseases
Interventions:   Drug: Liraglutide Pen Injector [Victoza];   Drug: Placebo
Sponsors:   RWTH Aachen University;   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/2Z78dJl